Global

Rare Disease Day is the globally-coordinated movement working towards equity in social opportunity, healthcare and access to diagnosis and therapies for those living with a rare disease.
This Personal View supports SDG 3 and 10 by discussing the ethical issues surrounding the use of psychedelic pharmacotherapies in Western medicine; as some of these agents are used in traditional medicines by Indigenous people. The authors make a series of recommendations on how these issues can be addressed.
Elsevier,

Shalini Rai, Ram Prasad, Chapter 1 - Biology, biodiversity, and biotechnology of Trichoderma, Editor(s): Shalini Rai, Ram Prasad,
New and Future Developments in Microbial Biotechnology and Bioengineering, Elsevier, 2023, Pages 1-28, ISBN 9780323998901

This content aligns with Goal 15: Life on Land by giving an overview of of trichoderma biology, biodiversity, and biotechnological approaches in the extreme conditions of climate.
Elsevier,

David E. Reichle, Chapter 9 - Ecosystem productivity, Editor(s): David E. Reichle, The Global Carbon Cycle and Climate Change (Second Edition), Elsevier, 2023, Pages 197-232, ISBN 9780443187759, https://doi.org/10.1016/B978-0-443-18775-9.00007-3.

This chapter advances the UN SDG goals 13, 14, and 15 by examining the global distribution of carbon in biomass.
Elsevier,

Rare, Available online 23 February 2023, In Press, Journal Pre-proof

On Rare Disease day, Elsevier has launched a new scientific journal called Rare. Open research in rare diseases. Elsevier dedicates a peer-reviewed publication specifically to these lesser known or unknown disorders, with the aim of having a clinical impact on the lives of patients and their families.
Elsevier,

David E. Reichle, Chapter 10 - The global carbon cycle and the biosphere, Editor(s): David E. Reichle, The Global Carbon Cycle and Climate Change (Second Edition), Elsevier, 2023, Pages 235-283, ISBN 9780443187759, https://doi.org/10.1016/B978-0-443-18775-9.00014-0.

This chapter advances the UN SDG goals 13, 14, and 15 by examining mathematical computer models of biogeochemical processes of atmosphere, land, and oceans can be represente, used to describe the past, present, and future dynamics of the Earth's carbon cycle
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by introducing the AI transformation of public health (PubHealth) uniting healthcare systems with the central terms, concepts, and history of PubHealth from ancient quarantines to modern vaccines including milestone developments as successful responses to chronic and infectious diseases, sanitation, workplace safety, poverty, and wars.
For Rare Disease Day 2023, RELX's Global Head of Corporate Responsibility, Márcia Balisciano, speaks to Shiv Gaglani, CEO & Co-Founder of Osmosis.
Elsevier, Current Opinion in Chemical Biology, Volume 72, February 2023
Despite being a relatively new addition to the Omics' landscape, lipidomics is increasingly being recognized as an important tool for the identification of druggable targets and biochemical markers. In this review we present recent advances of lipid analysis in drug discovery and development. We cover current state of the art technologies which are constantly evolving to meet demands in terms of sensitivity and selectivity. A careful selection of important examples is then provided, illustrating the versatility of lipidomics analysis in the drug discovery and development process.
Elsevier,

Clinical Decision Support and Beyond (Third Edition): Progress and Opportunities in Knowledge-Enhanced Health and Healthcare, 2023, Pages 715-725

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by discussing the components of a technical infrastructure to support PHM, including data sources (registries, electronic health records), data analytics tools, patient outreach and engagement tools, and patient tracking dashboards along with real-world examples of PHM programs focused on chronic disease management, genetic testing for hereditary cancers, colorectal cancer screening, COVID-19 testing and vaccination, and tobacco cessation.

Pages